PHASE 1 STUDY OF PRT1419 (MCL1 INHIBITOR) AS MONOTHERAPY OR IN COMBINATION WITH AZACITIDINE OR VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY MYELOID OR B‐CELL MALIGNANCIES

R. R. Zuniga, S. Nair,G. Keiffer,F. Ravandi‐Kashani,A. D. Goldberg,E. Traer,L. P. Frenzel,C. Röllig, G. Savickas,W. Sun, S. K. Atwal,W. Hong,S. E. Assouline

Hematological Oncology（2023）

引用 0|浏览9

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要